×

Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes

  • US 20040028660A1
  • Filed: 05/30/2003
  • Published: 02/12/2004
  • Est. Priority Date: 05/30/2002
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of modulating the differentiation of a mammalian stem cell comprising contacting the stem cell with a compound that modulates JNK or MKK activity, under conditions suitable for differentiation of said stem cell.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×